Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P N Durrington

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Postgraduate Medical Journal|October 1, 1991
Specific lipid lowering therapy in the management of diabetesP N Durrington
Atherosclerosis|January 15, 1999
Triglycerides are more important in atherosclerosis than epidemiology has suggestedP N Durrington
Atherosclerosis|November 12, 1998
Can we afford to treat hyperlipidaemia as we should? Strategies for rational treatmentP N Durrington
Bailliere'S Clinical Endocrinology and Metabolism|October 1, 1995
Lipoprotein (a)P N Durrington
British Heart Journal|February 1, 1994
Can any agreement be reached on cholesterol lowering?P N Durrington
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1990
Biological variation in serum lipid concentrationsP N Durrington
Lancet (London, England)|July 15, 1995
Implications of 4S evidence on baseline lipid levelsP N Durrington
Annals of Clinical Biochemistry|July 1, 1980
A comparison of three methods of measuring serum high density lipoprotein cholesterol in diabetics and non-diabeticsP N Durrington
Postgraduate Medical Journal|January 1, 1993
Diabetes, hypertension and hyperlipidaemiaP N Durrington
BMJ (Clinical Research Ed.)|August 19, 2000
Risk in cardiovascular disease. Joint British societies recommend their computer program for risk calculationsP N Durrington
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Postgraduate Medical Journal|October 1, 1991
Specific lipid lowering therapy in the management of diabetesP N Durrington
Atherosclerosis|January 15, 1999
Triglycerides are more important in atherosclerosis than epidemiology has suggestedP N Durrington
Atherosclerosis|November 12, 1998
Can we afford to treat hyperlipidaemia as we should? Strategies for rational treatmentP N Durrington
Bailliere'S Clinical Endocrinology and Metabolism|October 1, 1995
Lipoprotein (a)P N Durrington
British Heart Journal|February 1, 1994
Can any agreement be reached on cholesterol lowering?P N Durrington
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1990
Biological variation in serum lipid concentrationsP N Durrington
Lancet (London, England)|July 15, 1995
Implications of 4S evidence on baseline lipid levelsP N Durrington
Annals of Clinical Biochemistry|July 1, 1980
A comparison of three methods of measuring serum high density lipoprotein cholesterol in diabetics and non-diabeticsP N Durrington
Postgraduate Medical Journal|January 1, 1993
Diabetes, hypertension and hyperlipidaemiaP N Durrington
BMJ (Clinical Research Ed.)|August 19, 2000
Risk in cardiovascular disease. Joint British societies recommend their computer program for risk calculationsP N Durrington
Pageof 19